| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.659 | 18.835 | 25.450 | 0 | 0 | 0 | 0 | 0 | 5.399 | 22.131 |
| Total Income - EUR | 31.659 | 18.835 | 25.450 | 0 | 0 | 0 | 0 | 0 | 5.404 | 22.131 |
| Total Expenses - EUR | 28.111 | 23.012 | 28.232 | 0 | 0 | 0 | 0 | 0 | 6.752 | 27.908 |
| Gross Profit/Loss - EUR | 3.548 | -4.178 | -2.781 | 0 | 0 | 0 | 0 | 0 | -1.348 | -5.777 |
| Net Profit/Loss - EUR | 2.598 | -4.358 | -3.090 | 0 | 0 | 0 | 0 | 0 | -1.348 | -5.998 |
| Employees | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Biozei Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 26.899 | 22.609 | 377 | 0 | 0 | 0 | 0 | 0 | 25.181 | 21.710 |
| Inventories | 21.511 | 20.182 | 0 | 0 | 0 | 0 | 0 | 0 | 21.846 | 17.577 |
| Receivables | 4.565 | 2.451 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 823 | -23 | 377 | 0 | 0 | 0 | 0 | 0 | 3.335 | 4.133 |
| Shareholders Funds | -11.030 | -15.276 | -18.107 | 0 | -17.431 | -17.100 | -16.721 | -16.773 | -18.070 | -23.967 |
| Social Capital | 45 | 45 | 44 | 0 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 37.929 | 37.885 | 18.484 | 0 | 17.431 | 17.100 | 16.721 | 16.773 | 43.251 | 45.678 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Biozei Srl